These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 26667113)
1. Some pharmacokinetic indices of oral fluconazole administration to koalas (Phascolarctos cinereus) infected with cryptococcosis. Govendir M; Black LA; Jobbins SE; Kimble B; Malik R; Krockenberger MB J Vet Pharmacol Ther; 2016 Aug; 39(4):412-5. PubMed ID: 26667113 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of fluconazole following intravenous and oral administration to koalas (Phascolarctos cinereus). Black LA; Krockenberger MB; Kimble B; Govendir M J Vet Pharmacol Ther; 2014 Feb; 37(1):90-8. PubMed ID: 23889092 [TBL] [Abstract][Full Text] [Related]
3. Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus). Kido N; Makimura K; Kamegaya C; Shindo I; Shibata E; Omiya T; Yamamoto Y Med Mycol; 2012 Apr; 50(3):291-8. PubMed ID: 21859391 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration. Gharibi S; Kimble B; Vogelnest L; Barnes J; Stadler CK; Govendir M J Vet Pharmacol Ther; 2017 Dec; 40(6):675-681. PubMed ID: 28455999 [TBL] [Abstract][Full Text] [Related]
5. Cryptococcosis in the koala (Phascolarctos cinereus): pathogenesis and treatment in the context of two atypical cases. Schmertmann LJ; Stalder K; Hudson D; Martin P; Makara M; Meyer W; Malik R; Krockenberger MB Med Mycol; 2018 Nov; 56(8):926-936. PubMed ID: 29529308 [TBL] [Abstract][Full Text] [Related]
6. Review of some pharmacokinetic and pharmacodynamic properties of anti-infective medicines administered to the koala (Phascolarctos cinereus). Govendir M J Vet Pharmacol Ther; 2018 Feb; 41(1):1-10. PubMed ID: 28703410 [TBL] [Abstract][Full Text] [Related]
7. Preshipment testing success: resolution of a nasal sinus granuloma in a captive koala (Phascolarctos cinereus) caused by Cryptococcus gattii. Wynne J; Klause S; Stadler CK; Pye GW; Meyer W; Sykes JE J Zoo Wildl Med; 2012 Dec; 43(4):939-42. PubMed ID: 23272367 [TBL] [Abstract][Full Text] [Related]
8. Absorption of enrofloxacin and marbofloxacin after oral and subcutaneous administration in diseased koalas (Phascolarctos cinereus). Griffith JE; Higgins DP; Li KM; Krockenberger MB; Govendir M J Vet Pharmacol Ther; 2010 Dec; 33(6):595-604. PubMed ID: 21062313 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis. Santos JR; César IC; Costa MC; Ribeiro NQ; Holanda RA; Ramos LH; Freitas GJ; Paixão TA; Pianetti GA; Santos DA Eur J Pharm Sci; 2016 Sep; 92():235-43. PubMed ID: 27235581 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of cryptococcal antigenemia and nasal colonization in a free-ranging koala population. Schmertmann LJ; Kan A; Mella VSA; Fernandez CM; Crowther MS; Madani G; Malik R; Meyer W; Krockenberger MB Med Mycol; 2019 Oct; 57(7):848-857. PubMed ID: 30649397 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of meloxicam in koalas (Phascolarctos cinereus) after intravenous, subcutaneous and oral administration. Kimble B; Black LA; Li KM; Valtchev P; Gilchrist S; Gillett A; Higgins DP; Krockenberger MB; Govendir M J Vet Pharmacol Ther; 2013 Oct; 36(5):486-93. PubMed ID: 23406022 [TBL] [Abstract][Full Text] [Related]
12. Nasal mass removal in the koala (Phascolarctos cinereus). Bercier M; Wynne J; Klause S; Stadler CK; Gorow A; Pye GW J Zoo Wildl Med; 2012 Dec; 43(4):898-908. PubMed ID: 23272360 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profile of oral and subcutaneous administration of paracetamol in the koala (Phascolarctos cinereus) and prediction of its analgesic efficacy. Govendir M; Vogelnest L; Shapiro AJ; Marschner C; Kimble B PLoS One; 2024; 19(4):e0300703. PubMed ID: 38630750 [TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosis. Govendir M; Hanger J; Loader JJ; Kimble B; Griffith JE; Black LA; Krockenberger MB; Higgins DP J Vet Pharmacol Ther; 2012 Apr; 35(2):147-54. PubMed ID: 21569052 [TBL] [Abstract][Full Text] [Related]
15. In vitro binding of cefovecin to plasma proteins in Australian marsupials and plasma concentrations of cefovecin following single subcutaneous administration to koalas (Phascolarctos cinereus). Gharibi S; Vogelnest L; Govendir M Aust Vet J; 2019 Mar; 97(3):75-80. PubMed ID: 30809814 [TBL] [Abstract][Full Text] [Related]
16. Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing. Lortholary O; Nicolas M; Soreda S; Improvisi L; Ronin O; Petitjean O; Dupont B; Tod M; Dromer F J Antimicrob Chemother; 1999 Jun; 43(6):817-24. PubMed ID: 10404321 [TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of fluconazole after a single oral dose and administration in drinking water in cockatiels (Nymphicus hollandicus). Ratzlaff K; Papich MG; Flammer K J Avian Med Surg; 2011 Mar; 25(1):23-31. PubMed ID: 21657184 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients. Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457 [TBL] [Abstract][Full Text] [Related]
19. Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole. Choi KH; Park SJ; Min KH; Kim SR; Lee MH; Chung CR; Han HJ; Lee YC Scand J Infect Dis; 2011 May; 43(5):380-5. PubMed ID: 21271944 [TBL] [Abstract][Full Text] [Related]
20. In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis. Sinnollareddy MG; Roberts MS; Lipman J; Lassig-Smith M; Starr T; Robertson T; Peake SL; Roberts JA Antimicrob Agents Chemother; 2016 Feb; 60(2):827-32. PubMed ID: 26596947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]